Margaix-Muñoz M, Bagán J, Poveda-Roda
R. Intravenous bisphosphonate-related
osteonecrosis of the jaws: Influence of coadjuvant antineoplastic
treatment and study of buccodental condition. Med Oral Patol
Oral Cir Bucal. 2013 Mar 1;18 (2):e194-200.
doi:10.4317/medoral.18604
http://dx.doi.org/doi:10.4317/medoral.18604
|
1. Bagan
JV, Jiménez Y, Hernández S, Murillo J, Díaz JM, Poveda
R, et al. Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis:
a comparative study. Med Oral Patol Oral Cir
Bucal. 2009;14:e616-9. |
|
|
|
|
|
2. Bagán
J, Blade J, Cozar JM,
Constela M, García Sanz R, Gómez Veiga F, et al. Recommendations
for the prevention, diagnosis, and treatment of osteonecrosis
of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Med Oral Patol Oral Cir
Bucal. 2007;12:E336-40. |
|
|
|
|
|
3. Ruggiero
SL, Dodson TB, Assael LA,
Landesberg R, Marx RE, Mehrotra
B, et al. American Association of Oral and Maxillofacial Surgeons position paper
on bisphosphonate-related osteonecrosis
of the jaws--2009 update. J Oral Maxillofac Surg. 2009;67:2-12. |
|
|
|
|
|
4. Bagan JV, Hens-Aumente
E, Leopoldo-Rodado M, Poveda-Roda
R, Bagan L.Bisphosphonate-related
osteonecrosis of the jaws: study of the staging
system in a series of clinical cases. Oral
Oncol. 2012;48:753-7. |
|
|
|
|
|
5. Fedele S, Porter SR, D'Aiuto
F, Aljohani S, Vescovi P,
Manfredi M, et al. Nonexposed
variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med. 2010;123:1060-4. |
|
|
|
|
|
6. Bagan JV, Jimenez Y, Diaz JM, Murillo J, Sanchis JM, Poveda R, et al.Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the
clinical classification. Oral Oncol. 2009;45:645-6. |
|
|
|
|
|
7. Aghaloo TL, Felsenfeld
AL, Tetradis S. Osteonecrosis
of the jaw in a patient on Denosumab. J Oral Maxillofac Surg. 2010;68:959-63. |
|
|
|
|
|
8. Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci. 2011;1218:38-46. |
|
|
|
|
|
9. Gómez-Font R,
Martínez-García ML, Olmos-Martínez JM. Osteochemonecrosis of the jaws due
to bisphosphonate treatments. Update. Med Oral Patol Oral Cir Bucal. 2008;13:E318-24. |
|
|
|
|
|
10. Bagan
JV, Murillo J, Jimenez Y, Poveda
R, Milian MA, Sanchis JM,
et al. Avascular jaw osteonecrosis
in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med. 2005;34:120-3. |
|
|
|
|
|
11. Bagan
JV, Jimenez Y, Murillo J, Hernandez
S, Poveda R, Sanchis JM,
et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its
relationship to teeth extractions. Study of 20 cases. Oral Oncol. 2006;42:327-9. |
|
|
|
|
|
12. Siddiqi A, Payne AG, Zafar
S. Bisphosphonate-induced osteonecrosis
of the jaw: a medical enigma?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e1-8. |
|
|
|
|
|
13. Such
E, Cervera J, Terpos E, Bagán
JV, Avaria A, Gómez I, et al. CYP2C8 gene
polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple
myeloma. Haematologica. 2011;96:1557-9. |
|
|
|
|
|
14. Advisory Task Force on Bisphosphonate-Related
Ostenonecrosis of the Jaws, American Association of
Oral and Maxillofacial Surgeons. American Association of Oral and
Maxillofacial Surgeons position paper on bisphosphonate-related
osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-76. |
|
|
|
|
|
15. Ponte Fernández N, Estefania Fresco R, Aguirre Urizar
JM. Bisphosphonates and oral pathology I.
General and preventive aspects. Med
Oral Patol Oral Cir Bucal. 2006;11:E396-400. |
|
|
|
|
|
16. Knutson JW. Workshop in dental health planning; present status of preventive
procedures. J Or
State Dent Assoc. 1947;16:34-43. |
|
|
|
|
|
17. Carmagnola D, Celestino
S, Abati S. Dental and periodontal history of
oncologic patients on parenteral bisphosphonates with or without osteonecrosis
of the jaws: a pilot study.Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2008;106:e10-5. |
|
|
|
|
|
18. Compston J. Pathophysiology
of atypical femoral fractures and osteonecrosis of
the jaw. Osteoporos Int. 2011;22:2951-61. |
|
|
|
|
|
19. Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin
L, et al. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple
myeloma: an overview with recommendations for prevention and treatment.
Intern Med J. 2009;39:304-16. |
|
|
|
|
|
20. Migliorati CA, Epstein JB, Abt E, Berenson JR. Osteonecrosis
of the jaw and bisphosphonates in cancer: a
narrative review. Nat Rev Endocrinol.
2011;7:34-42. |
|
|
|
|
|
21. Sardella A, Carrassi
A, Tarozzi M, Lodi G. Bisphosphonate-related
osteonecrosis of the jaws associated with
photodynamic therapy. J Oral Maxillofac Surg. 2011;69:e314-6. |
|
|
|
|
|
22. Khosla S, Burr D, Cauley
J, Dempster DW, Ebeling
PR, Felsenberg D, et al. Bisphosphonate-associated
osteonecrosis of the jaw: report of a task force of
the American Society for Bone and Mineral Research. J Bone Miner
Res. 2007;22:1479-91. |
|
|
|
|
|
23. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular
necrosis of the jaws: a growing epidemic. J
Oral Maxillofac Surg.
2003;61:1115-7. |
|
|
|
|
|
24. Thumbigere-Math V, Sabino
MC, Gopalakrishnan R, Huckabay
S, Dudek AZ, Basu S, et
al. Bisphosphonate-related osteonecrosis
of the jaw: clinical features, risk factors, management, and treatment
outcomes of 26 patients. J Oral Maxillofac Surg. 2009;67:1904-13. |
|
|
|
|
|
25. Boonyapakorn T, Schirmer
I, Reichart PA, Sturm I, Massenkeil
G. Bisphosphonate-induced osteonecrosis
of the jaws: prospective study of 80 patients with multiple myeloma and other
malignancies. Oral Oncol.
2008;44:857-69. |
|
|
|
|
|
26. Jensen SB, Mouridsen HT, Bergmann OJ, Reibel J, Brünner N, Nauntofte B. Oral mucosal lesions, microbial changes, and
taste disturbances induced by adjuvant chemotherapy in breast cancer patients.Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 2008;106:217-26. |
|
|
|
|
|
27. Napeñas JJ, Brennan MT, Coleman S, Kent
ML, Noll J, Frenette G, et al. Molecular
methodology to assess the impact of cancer chemotherapy on the oral bacterial
flora: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:554-60. |
|
|
|
|
|
28. Dimopoulos
MA, Kastritis E, Bamia C,
Melakopoulos I, Gika D, Roussou M, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of
preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann
Oncol. 2009;20:117-20. |
|
|
|
|
|
29. Nicolatou-Galitis
O, Papadopoulou E, Sarri
T, Boziari P, Karayianni
A, Kyrtsonis MC, et al. Osteonecrosis of the jaw in
oncology patients treated with bisphosphonates:
prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:195-202. |
|